Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Fujian Yango $175 million high-yield notes offering
Davis Polk advised the joint lead managers in connection with the Regulation S offering of $175 million principal amount of 11.875% senior notes due 2023 by Yango (Cayman) Investment…
RemeGen HK$4 billion Hong Kong IPO
Davis Polk advised the underwriters in the initial public offering of RemeGen Co., Ltd. on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule 144A…
JW (Cayman) Therapeutics HK$2.33 billion Hong Kong IPO
Davis Polk advised the underwriters in the initial public offering of JW (Cayman) Therapeutics Co. Ltd on the Hong Kong Stock Exchange and an international offering and listing in reliance…
Meituan $2 billion debut senior notes offering
Davis Polk advised the initial purchasers in connection with the Rule 144A/Regulation S offering by Meituan of $750 million 2.125% senior notes due 2025 and $1.25 billion 3.050% senior…
Baidu $950 million notes offering
Davis Polk advised the underwriters on an SEC-registered offering by Baidu, Inc. of its $650 million 1.720% notes due 2026 and $300 million 2.375% notes due 2030. Baidu, Inc. is a leading…
Boqii Holding $70 Million IPO and NYSE listing
Davis Polk advised Boqii Holding Limited on its SEC-registered initial public offering of 7,000,000 American depositary shares. Each ADS represents 0.75 Class A ordinary share of Boqii…
Back to top